AzTrials
AzTrials

Self-harmNCT05171192

Culturally Adapted CMAP Plus LTP for Refugee Mothers with History of Self-harm in Pakistan

A study testing CMAP Plus LTP in people with Self-harm and Child Development, run by Pakistan Institute of Living and Learning at 2 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objectives: To asses the feasibility and acceptability of a culturally adapted manual assisted brief psychological intervention (CMAP) plus Learning through Play (LTP) for refugee mothers with history of self-harm having children 0-33 months. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Self-harm, Child Development
What is being tested?
CMAP Plus LTP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesPakistan
Study dates
1 Apr 2022to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years and above refugee mothers with children aged between 0-33 months.
  • History of self-harm.
  • Resident in the study site.
  • Capacity to provide informed consent.
  • Available for the duration of the study.

Who cannot join

  • Unable to provide consent due to severe mental or physical illness.
  • Unlikely to be available for the entire duration of the study.

Trial locations and contacts

2 sites in 1 country.

Pakistan2 sites
  • Community settings

    Peshawar, KPK, 25000

  • Community Settings

    Quetta, Balochistan, 87300

Other trials in Pakistan

About this study

Official title: Feasibility Study of a Culturally Adapted Manual Assisted Brief Psychological Intervention (CMAP) Plus Learning Through Play (LTP) for Refugee Mothers with History of Self-harm in Pakistan

Objectives:

  • To asses the feasibility and acceptability of a culturally adapted manual assisted brief psychological intervention (CMAP) plus Learning through Play (LTP) for refugee mothers with history of self-harm having children 0-33 months. (Integrated intervention called CMAP Plus)
  • To assess if CMAP Plus will reduce the repetition of self-harm in refugee mothers having children aged between 0-33 months.
  • To determine if the intervention improves infant development and maternal attachment.
  • To explore participants experiences with the intervention.
Read more

Study design and setting:

This will be a feasibility cluster randomized control trial (cRCT) of culturally adapted CMAP Plus LTP intervention with refugee mothers from Quetta and Peshawar, Pakistan.

Sample size:

We aim to recruit a sample of 80 refugee mothers in the study.

Read the detailed description

Mental health of refugees particularly mothers living in camps or in conflict areas is one of the most important issues needing special attention and intervention. Culturally adapted Manual Assisted brief Psychological intervention (CMAP) utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice in reducing repetition of self-harm in people who had recently self-harmed. Similarly, LTP programme promotes child health by supporting attuned interaction between mother and child, increasing maternal awareness of the physical and emotional needs of young children, and encouraging nurture and attachment. The CMAP plus LTP intervention may contribute significantly to the evidence base of addressing mental health of refugee mothers. This study aims to evaluate whether CMAP Plus LTP is feasible, acceptable for this population and helpful to reduce the repetition of self-harm and improve child development among refugee mothers with a history of self-harm. Eligible consented participants will complete the baseline assessments using structured questionnaires. Unit of randomization will be the Union Council. Uniion councils have been slected by the research team through consultations with community advisory committees from both sites. Selected UCs will be randomized into two study arms: 1) C-MAP plus LTP added to treatment as usual and 2) Treatment as usual (TAU) alone. Participants in intervention arm will receive 10 individual sessions of CMAP plus LTP intervention for a period of 12 weeks. All sessions will be delivered by female therapists trained in CMAP Plus. Participants in TAU alone group will receive routine care that includes routine follow up by Community Health Workers (CHWs) in Pakistan. Assessments will be carried out at baseline, and completion of the intervention at 12th week (after intervention). All assessments will be rater-blind (done by independent RAs (female), not involved in delivering the intervention sessions). After post-assessments, a purposefully selected subset (stratified by age) of participants will be invited for qualitative interviews (n = up to 15 interviews) to explore their experiences and satisfaction with the intervention. On average, interviews will last for 60-90 minutes.

Being tested
CMAP Plus LTP
Keywords
Self-harm, Child development, Refugee mothers, CMAP, Learning through Play, LTP, Pakistan
Medical subject headings
Self-Injurious Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CMAP Plus LTPBehavioural

    The LTP Plus CMAP intervention will be delivered for a period of 12 weeks, including 8 weekly sessions and 2 sessions fortnightly. First 6 sessions will be for a duration of 60-90 minutes and remaining 4 sessions will take approximately 50-60 minutes. All sessions will be delivered by female therapists trained in CMAP and LTP intervention.

Study groups in NCT05171192
Study groupRoleWhat they receive
CMAP Plus LTP added to TAUExperimentalC-MAP is a manual assisted intervention based on the principles of CBT which is focused on evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking, and relapse prevention strategies. As family conflicts are a common issue with this group one session is focused on the use of culturally sensitive training in assertiveness and conflict management. The LTP is a community-based parenting intervention designed to deal with early child development. The central feature of the LTP intervention is a pictorial calendar devised for parents which depicts eight successive stages of child development from birth to 3 years along with illustrations of parent-child play and other activities that promote parental involvement, learning, and attachment. This will be added to Treatment as Usual
Receives: Behavioral: CMAP Plus LTP
TAU aloneNo interventionTAU alone will include routine follow up by Community Health Workers (CHWs) in Pakistan. Their work includes assisting with all aspects of maternal, new-born and childcare. Participants in treatment as usual arm will receive routine care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility measure

    The feasibility will be determined by collating data on recruitment and retention rates. The success criterion of feasibility will be to recruit > 50% of eligible participants.

    Measured: From baseline to 12th week (at the end of intervention)

  2. Acceptability measure

    The intervention acceptability will be assessed using data on attendance. Criterion for acceptability is a mean attendance rate of >70% of at least 7 sessions.

    Measured: From baseline to 12th week (at the end of intervention)

Secondary outcomes (15)
  1. Suicide Attempt Self-Injury Interview

    Repetition rate of self-harm at 3 months after randomisation as measured by adapted Suicide Attempt Self-Injury Interview. The questionnaire records self-harm events by severity and chronological order.

    Measured: From baseline to 12th week

  2. Beck Scale for Suicide Ideation

    This is a 19-item instrument for detecting and measuring the current intensity of the patients' specific attitudes, behaviours, and specificity of a patient's thoughts to kill him/herself during the past week.

    Measured: Change in problem scores from baseline to 12th week

  3. Beck Depression Inventory

    This is a 21 items scale measuring symptoms of depression. Higher scores on the scale indicate greater severity of depression.

    Measured: Change in problem scores from baseline to 12th week

  4. Beck Hopelessness Scale

    This instrument is designed to measure three aspects of hopelessness, feelings about the future, loss of motivation and expectations.

    Measured: Change in problem scores from baseline to 12th week

  5. Generalized Anxiety Disorder

    This is a 7-item scale used to screen for and measure severity of Generalized Anxiety Disorder.

    Measured: Change in problem scores from baseline to 12th week

  6. Assessment of the growth and development of children

    Anthropometric measures of child growth will be collected through measuring children's height, weight and head circumference

    Measured: Change from baseline to 12th week

  7. Ages and Stages Questionnaire and ASQ Socio-emotional Scales

    Ages and Stages Questionnaire and ASQ Socio-emotional scales will be used to measure child development. Parents will report on their child's communication, gross motor, fine motor, problem solving and personal-social development at different time points.

    Measured: Change from baseline to 12th week

  8. Coping resource inventory

    Coping resource inventory will assess the coping resources to manage stress available to an individual.

    Measured: Change from baseline to 12th week

  9. Problem Solving Inventory

    The Problem-Solving Inventory assesses an individual's awareness and evaluation of his or her problem-solving abilities or styles. The problem-solving Inventory is a self-report measure, and thus assesses perceptions of problem solving as opposed to actual problem-solving skills.

    Measured: Change in problem scores from baseline to 12th week

  10. Infant Development Questionnaire

    Infant Development Questionnaire is a 20-item questionnaire of paternal knowledge and expectations for child development in the first three years.

    Measured: Change from baseline to 12th week

  11. Parenting Stress Index - Short Form

    Parents rated 36 item scale on five-point scale (1-5). The scale consists of three subscales: (1) Parenting Distress, (2) Difficult Child Characteristics, and (3) Dysfunctional Parent-Child Interaction.

    Measured: Change from baseline to 12th week

  12. Multidimensional Scale of Perceived Social Support

    This brief scale will assess perceived social support.

    Measured: Change from baseline to 12th week

  13. Euro-Qol-5 Dimensions scale

    Health-related quality of life will be measured using the Euro-Qol-5 Dimensions scale. This is a standardized instrument that measures five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each scored from 1 to 3 indicating "no problem" to "severe problems".

    Measured: Change in problem scores from baseline to 12th week

  14. Client Service Receipt Inventory

    This inventory will collect information about the use of other health services (including the informal sector faith healers/Imams) using CSRI based on our previous work in Pakistan

    Measured: Change from baseline to 12th week

  15. Client Satisfaction Questionnaire

    The participants will rate their satisfaction with treatment using the Client Satisfaction Questionnaire.

    Measured: Change from baseline to 12th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2021
  2. Study start1 Apr 2022
  3. Primary completion15 Dec 2023
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05171192
Sponsor's protocol ID
SAHAR M-CMAP Plus LTP-002
Status last verified
Dec 2024
First submitted
11 Dec 2021
Last updated
10 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CMAP Plus LTP in people with Self-harm and Child Development, run by Pakistan Institute of Living and Learning at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility measure (time frame: From baseline to 12th week (at the end of intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in